NEW YORK, May 2, 2022 /PRNewswire/ — The American Skin Association has announced the names of the two winners receiving the coveted research fellowship as part of the ASA Milstein Research Fellowships program. This year Angel ByrdMD, PhD of Howard University College of Medicine, and Jennifer GilMD, PhD of University of Texas Southwestern Medical Center were selected to receive the ASA Milstein Melanoma/Non-Melanoma Skin Cancer Fellowship Subsidies.

ASA Logo (PRNewsfoto/American Skin Association)

Another grant sought includes the ASA Daneen & Charles Stiefel Investigative Scientist Award in Melanoma Research. Nicholas GulatiMD, PhD from the Icahn School of Medicine in Mount Sinai was selected to receive the award. Over the years, the Stiefel family, longtime supporters of the ASA, have generously contributed $600,000 to support grants for melanoma research. This funding aims to support emerging leaders in dermatology, who are focused on better understanding melanoma, in the hope of finding a cure.

In addition, 5 other research grants, made possible through the generosity of individuals, foundations and corporations, have also been announced.

For thirty-five years, in advancing its vital mission to serve the more than 100 million Americans with skin disorders, ASA and its affiliates have funded more than $50 million in grants. The main goal of ASA is to improve treatments and to continue working towards the cure of melanoma, vitiligo, psoriasis, atopic dermatitis and other skin diseases.

“These grants in support of cutting-edge dermatological research are critical to advancing ASA’s goal of defeating skin cancers like melanoma. Although the skin is our largest and perhaps most exposed organ, dermatological research remains one of the most underfunded areas of medicine. will improve the odds of finding the long-sought cure and bring hope to the millions of people suffering from devastating skin cancer and other skin diseases,” said ASA President, Howard P. Milstein.

The ASA grant program is managed by its Medical Advisory Committee (MAC), made up of eminent scientists and physicians who volunteer their time to oversee the annual grant process. Through their leadership, the ASA grant program has supported the work of more than 300 researchers, ranging from talented early-career researchers to recognized leaders in the field of dermatology.

“The ASA Medical Advisory Board is delighted to announce the 2022 awards. This year’s recipients signal the growing power of research in basic, translational and clinical dermatology. Never before have advances in basic research led so quickly to new therapeutic approaches New treatments for vitiligo, psoriasis, atopic dermatitis, melanoma and other types of skin cancer are upon us, fueled by significant financial contributions from the ASA said ASA President and MAC Co-Chair Dr. David A. Norris.

The ASA offers substantial research grants to established researchers and medical students studying melanoma, non-melanoma skin cancer, and other skin diseases. Through these grants, the ASA has nurtured the early careers of many talented young researchers and has had a profound influence on both dermatological research and the clinical care of dermatological diseases. Over the years, ASA-funded researchers have had a tremendous impact on the understanding of melanoma by improving our understanding of diagnosis, treatment and prognosis. By focusing exclusively on research into skin diseases, ASA has helped open new frontiers in skin science by producing results that will change the way we understand and treat these diseases.

Here are the recipients of the 2022 Research Scientist Scholarship, Fellowships, Research Grants, and Medical Student Scholarships:

2022 ASA Daneen & Charles Stiefel Investigative Scientist Award for Melanoma Research
Nicholas GulatiMD, PhD
Icahn School of Medicine at Mount Sinai
Project title: Use of topical Diphencyprone to improve the effectiveness of checkpoint inhibition in patients with melanoma.

ASA Milstein Fellowship 2022 for Melanoma/Non-Melanoma Skin Cancer
Angel ByrdMD, PhD
Howard University medical college
Project title: Examination of gene expression in Mycosis Fungoides in Skin of Color.

ASA Milstein Fellowship 2022 for Melanoma/Non-Melanoma Skin Cancer
Jennifer GilMD, PhD
University of Texas Southwestern Medical Center
Project title: Characterize the role of GAPDHS as a metastatic suppressor in human melanoma.

2022 ASA Calder Research Scholar Award in Vitiligo/Pigment Cell Disorders
Jessica ShiuMD, PhD
University of California Irvine
Project title: Investigation of the role of keratinocyte-derived signaling networks in the initiation of vitiligo.

2022 ASA Mulvaney Family Foundation Research Grant in Vitiligo and Pigment Cell Disorders
Ahmad AleissaMD, FAAD
Medical University of South Carolina
Project title: Daily topical therapy with rapamycin (sirolimus) for the treatment of vitiligo.

2022 ASA Castle Biosciences Melanoma Fellowship
Goran MicevicMD, PhD
Yale School of Medicine
Project title: Epigenetic Regulation of Slamf6 as a Therapeutic Strategy in Melanoma Immunotherapy.

ASA 2022 Scholarship for Medical Students Targeting Melanoma and Skin Cancer
M/s. Angela Adams
University of Arizona College of Medicine – Phoenix
Project title: New model of cutaneous squamous cell carcinoma to study tumor-specific T cell responses.

ASA 2022 Scholarship for Medical Students Targeting Melanoma and Skin Cancer
M/s. Victoria Mroz
Icahn School of Medicine in Mount Sinai
Project title: Role of ETS Transcription Factors in Heterogeneity of Cutaneous Squamous Cell Carcinoma Subpopulation.


A unique collaboration of patients, families, advocates, physicians and scientists, ASA has evolved over the past thirty-five years as a leading force in efforts to defeat melanoma, vitiligo, psoriasis, atopic dermatitis and other skin diseases. Created to serve the more than 100 million Americans – one-third of the US population – who suffer from skin disorders, the organization’s mission remains to: advance research, advocate for skin health, especially in children , and raise public awareness of skin diseases. ASA is a 501(c)3 non-profit organization. For more information, visit

The American Skin Association has earned Candid’s platinum transparency seal.



View original content for multimedia download:

SOURCE American Skin Association